Diabetic Macular Edema — First-In-Human Study of CU06-1004 Following Single and Multiple Ascending Doses in Healthy Volunteers
Citation(s)
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Doses of CU06-1004 in Healthy Subjects